Protalix's PRX-115 shows promising Phase 1 data for chronic refractory gout, with long-term urate reduction after a single dose, but faces significant competition and safety concerns. Protalix's ...
The image depicts uric acid paste. Laboratory assessment revealed negatively birefringent intracellular crystals consistent with gout. The next best step in treatment would be to refer the patient to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback